These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6271818)

  • 41. Concise review of the management of iatrogenic emesis using cannabinoids: emphasis on nabilone for chemotherapy-induced nausea and vomiting.
    Pergolizzi JV; Taylor R; LeQuang JA; Zampogna G; Raffa RB
    Cancer Chemother Pharmacol; 2017 Mar; 79(3):467-477. PubMed ID: 28235999
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nabilone: an effective antiemetic in patients receiving cancer chemotherapy.
    Einhorn LH; Nagy C; Furnas B; Williams SD
    J Clin Pharmacol; 1981; 21(S1):64S-69S. PubMed ID: 6271844
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cannabinoids: the lows and the highs of chemotherapy-induced nausea and vomiting.
    Mortimer TL; Mabin T; Engelbrecht AM
    Future Oncol; 2019 Mar; 15(9):1035-1049. PubMed ID: 30720344
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A marihuana component for nausea and vomiting induced by chemo- and radiotherapy].
    Gez E; Biran S; Fuks Z; Edelstein E; Lander N; Mechoulam R
    Harefuah; 1983 Nov; 105(10):306-8. PubMed ID: 6323286
    [No Abstract]   [Full Text] [Related]  

  • 45. Pharmacological management of chemotherapy-induced nausea and vomiting in children with cancer.
    Cefalo MG; Ruggiero A; Maurizi P; Attinà G; Arlotta A; Riccardi R
    J Chemother; 2009 Dec; 21(6):605-10. PubMed ID: 20071282
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An efficient new cannabinoid antiemetic in pediatric oncology.
    Abrahamov A; Abrahamov A; Mechoulam R
    Life Sci; 1995; 56(23-24):2097-102. PubMed ID: 7776837
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical Data for the Use of Cannabis-Based Treatments: A Comprehensive Review of the Literature.
    Inglet S; Winter B; Yost SE; Entringer S; Lian A; Biksacky M; Pitt RD; Mortensen W
    Ann Pharmacother; 2020 Nov; 54(11):1109-1143. PubMed ID: 32483988
    [TBL] [Abstract][Full Text] [Related]  

  • 48. THC or Compazine for the cancer chemotherapy patient--the UCLA study. Part II: Patient drug preference.
    Ungerleider JT; Sarna G; Fairbanks LA; Goodnight J; Andrysiak T; Jamison K
    Am J Clin Oncol; 1985 Apr; 8(2):142-7. PubMed ID: 3010696
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An overview of ondansetron for chemotherapy-induced nausea and emesis.
    San Angel F
    J Intraven Nurs; 1993; 16(2):84-9. PubMed ID: 8478782
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cancer and chemotherapy-induced nausea and vomiting: a focus on olanzapine.
    Bosnjak SM; Dimitrijevic J; Djordjevic F
    Curr Opin Support Palliat Care; 2016 Jun; 10(2):180-8. PubMed ID: 27028050
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of nausea and vomiting caused by anticancer drugs: state of the art.
    Pisters KM; Kris MG
    Oncology (Williston Park); 1992 Feb; 6(2 Suppl):99-104. PubMed ID: 1532744
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dronabinol treatment of refractory nausea and vomiting related to peritoneal carcinomatosis.
    Hernandez SL; Sheyner I; Stover KT; Stewart JT
    Am J Hosp Palliat Care; 2015 Feb; 32(1):5-7. PubMed ID: 24052427
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis.
    Machado Rocha FC; Stéfano SC; De Cássia Haiek R; Rosa Oliveira LM; Da Silveira DX
    Eur J Cancer Care (Engl); 2008 Sep; 17(5):431-43. PubMed ID: 18625004
    [TBL] [Abstract][Full Text] [Related]  

  • 54. THC: "transitional drug' for emesis therapy?
    Macek C
    JAMA; 1982 May; 247(19):2648-50, 2655. PubMed ID: 6281484
    [No Abstract]   [Full Text] [Related]  

  • 55. Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide regimens in patients with cancer: a randomised, active-controlled, double-blind, phase 3 trial.
    Schwartzberg LS; Modiano MR; Rapoport BL; Chasen MR; Gridelli C; Urban L; Poma A; Arora S; Navari RM; Schnadig ID
    Lancet Oncol; 2015 Sep; 16(9):1071-1078. PubMed ID: 26272768
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trimethobenzamide HCl in the treatment of nausea and vomiting associated with antineoplastic chemotherapy.
    Hurley JD; Eshelman FN
    J Clin Pharmacol; 1980; 20(5-6 Pt 1):352-6. PubMed ID: 7400373
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of combined doses of Δ(9)-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea using rat (Sprague- Dawley) models of conditioned gaping.
    Rock EM; Limebeer CL; Parker LA
    Psychopharmacology (Berl); 2015 Dec; 232(24):4445-54. PubMed ID: 26381155
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patient Counseling Guidelines for the Use of Cannabis for the Treatment of Chemotherapy-Induced Nausea/Vomiting and Chronic Pain.
    Makary P; Parmar JR; Mims N; Khanfar NM; Freeman RA
    J Pain Palliat Care Pharmacother; 2018 Dec; 32(4):216-225. PubMed ID: 31070496
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy, tolerability, and safety of cannabinoids for chemotherapy-induced nausea and vomiting--a systematic review of systematic reviews.
    Tafelski S; Häuser W; Schäfer M
    Schmerz; 2016 Feb; 30(1):14-24. PubMed ID: 26787227
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adverse reactions to delta-9-tetrahydrocannabinol given as an antiemetic in a multicenter study.
    Devine ML; Dow GJ; Greenberg BR; Holstein DW; Icaza L; Jue PY; Meyers FH; O'Brien E; Roberts CM; Rocchio GL
    Clin Pharm; 1987 Apr; 6(4):319-22. PubMed ID: 2822339
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.